Start here if you're new
what it is
Itron sells hardware and software that help utilities run water, power, and city networks across three segments.
how it gets paid
Last year Itron made $2.4B in revenue. Networked Solutions was the main engine at $1.63B, or 68% of sales.
why growth slowed
Revenue fell 3.0% last year. Factors like accelerating load growth, rising costs, regulatory scrutiny, and technical demands are pushing customers to reassess their project time lines and investment priorities.
what just happened
Itron beat by ~13% on the last report, with quarter revenue near ~$600M (~¼ of $2.4B) and gross margin about 36.8% — not $1.8B in one quarter.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
10/100 earnings predictability — expect surprises
15.3x trailing p/e — the market's not buying it — or you found a deal
9.0% return on capital — nothing to write home about
xvary composite: 57/100 — below average
What they do
Itron sells hardware and software that help utilities run water, power, and city networks across three segments.
Utilities do not rip out networks quickly. Networked Solutions (connected meters and grid gear) is 68% of revenue, about $1.63B of the $2.4B total. That gives you a business built into essential infrastructure, where leaving costs more than staying.
How they make money
$2.4B
annual revenue · their business grew -3.0% last year
Networked Solutions
$1.63B
Device Solutions
$0.48B
Outcomes
$0.29B
The products that matter
connected utility infrastructure
Critical Infrastructure
$2.4B revenue · effectively the whole story here
the snapshot treats this as the full $2.4B business. that's useful because it tells you where the risk sits: if utilities delay projects, it hits the main engine, not a side segment.
core
software and services layer
Outcomes and recurring revenue
growth theme · no standalone revenue disclosed here
management is pointing you toward recurring revenue and software, but this snapshot does not give a segment number. that matters because the investment case depends on mix improvement, and the data here cannot yet prove how large that contribution is.
watch the mix
Key numbers
$137
18mo target
That is $32.52 above $104.48, or 31% upside from the current price.
15.3x
trailing P/E
You pay 15.3 times trailing earnings, so the stock is priced like a steady compounder, not a lottery ticket.
14.0%
op margin
Every $100 of sales keeps $14 before interest and taxes.
$811M
long debt
That debt is 14% of capital, so leverage is real but not reckless.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 35 / 100
- long-term debt $811M (14% of capital)
- net profit margin 12.7% — keeps 13 cents of every dollar in revenue
- return on equity 12% — $0.12 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in ITRI 3 years ago → it's now worth $18,430.
The index would have given you $13,880.
source: institutional data · total return
What just happened
beat estimates
Itron beat by ~13% on the last report, with quarter revenue near ~$600M and gross margin at 36.8%.
Drop +209% revenue vs. prior year / +205% EPS vs. prior year — incompatible with a −3% revenue year on $2.4B. Backlog and margin discipline still drive the story.
~$600M
quarter revenue (approx.)
$4.30
eps (Q · print)
36.8%
gross margin (Q)
the number that mattered
The 13.36% beat matters because this stock trades on execution, and the last quarter proved it can still surprise.
-
another key opportunity lies in itron’s outcomes segment, which focuses on software and services.
-
this area has reflected steady growth, with recurring revenue increasing from a year ago.the company’s acquisition of urbint, a SaaS-based business specializing in operational resilience solutions for utilities, is expected to further expand itron’s portfolio and create new revenue streams. by combining urbint’s capabilities with its own data-driven solutions, itron can offer utilities more comprehensive tools for emergency preparedness, damage prevention, and worker safety.
-
there are risks to consider.
-
one of the key challenges is the complex environment in which utilities operate.factors like accelerating load growth, rising costs, regulatory scrutiny, and technical demands are pushing customers to reassess their project time lines and investment priorities. this has led to delays in project deployments, particularly for hardwareoriented initiatives, as utilities spread out their budgets over longer periods. while these delays don’t necessarily mean project cancellations, they can create short-term uncertainty and affect revenue growth.
-
itron’s financial position appears well-equipped to support shareholder value.the balance sheet is decent, with cash and equivalents of $1.33 billion at the end of the third quarter, exceeding total debt of $1.27 billion.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the top risk is utility deployment delays on metering and grid projects.
med
utility deployment delays
utilities are dealing with rising costs, grid-load pressures, and regulatory oversight. when customers spread budgets over longer periods, a company with $2.4B in revenue and one main business line feels it quickly.
the direct issue is timing. if deployments slip, reported revenue can stay under pressure even when demand has not disappeared.
med
software mix fails to scale fast enough
management is pointing investors toward recurring revenue and the outcomes segment, but this page does not disclose a standalone segment size. that makes it harder for you to judge whether software is a real earnings engine yet or still a story in development.
if recurring revenue stays too small relative to the $2.4B base, the stock remains tied to hardware timing and project cycles.
med
earnings volatility
earnings predictability is just 10 / 100. that is the market telling you results can come in lumpy, and the FY2025 EPS pattern backs that up with a $2.17 Q4 after three smaller quarters.
at 15.3x earnings, the valuation is not demanding. but it also is not so cheap that repeated estimate cuts would be painless.
with the snapshot effectively showing one $2.4B revenue engine, delays in utility spending or a slower move toward recurring software revenue would pressure the whole story, not a side segment.
source: institutional data · regulatory filings · risk analysis
Pay attention to
earnings
next quarterly report
you want to see whether EPS stays closer to the $2.17 Q4 level or falls back toward the earlier quarterly run-rate.
trend
recurring revenue mix
software and services are the stated growth path. if management keeps talking about mix but total company revenue stays soft, you will know the shift is not large enough yet.
risk
utility project timing
listen for any change in deployment schedules, customer budgets, or regulatory bottlenecks. this is the cleanest read-through to near-term revenue.
metric
fy2026 estimates
the current setup is $6.00 EPS and roughly $2B of revenue. estimate revisions will tell you whether the street still believes the 31% upside case.
Analyst rankings
short-term outlook
average
momentum score 3. in human-speak, analysts think this is moving like a normal stock, not a fresh breakout.
risk profile
average
stability score 3 means the risk profile is middle of the pack. not a bunker stock, not a disaster case.
chart momentum
below average
technical score 4 means the chart setup is weaker than average from here. translation: price action is not doing the thesis any favors.
earnings predictability
10 / 100
this is the warning label. analysts do not see a smooth earnings stream here, so surprises should not surprise you.
source: institutional data
Institutional activity
institutions have been net selling for 2 consecutive quarters — 214 buyers vs. 215 sellers in 3q2025. total institutional holdings: 50.6M shares. net selling for 2 quarters.
source: institutional data
Price targets
3-5 year target range
$87
$186
$104
current price
$137
target midpoint · +31% from current · 3-5yr high: $225 (+115% · 21% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive